ProCE Banner Activity

Aiming High for Our Patients with Ulcerative Colitis: My Take on Treat-to-Target

Clinical Thought

Anita Afzali, MD describes her approach to goal setting when treating and monitoring patients with ulcerative colitis.

Released: July 26, 2022

Expiration: July 25, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Anita Afzali

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Professor of Clinical Medicine
Division of Digestive Diseases
Executive Vice Chair
Department of Internal Medicine
Associate Chief Medical Officer
University of Cincinnati, UC Health System
Co-Founder
The Scrubs & Heels Foundation
Cincinnati, Ohio

Acknowledgement

This activity is supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.

This activity is supported by educational grants from Amgen; and Ferring Pharmaceuticals, Inc.

Provided by

ProCE Banner

Supporters

Amgen

Ferring Pharmaceuticals, Inc.

Target Audience

NPs and PAs

Disclosure

Anita Afzali, MD, MPH, MHCM, FACG, AGAF: consultant/advisor/speaker: AbbVie, DiaSorin, Gilead Sciences, Janssen, Lilly, Pfizer, Takeda, TLL Pharmaceuticals.

None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.

Format

ClinicalThought

Additional Information

Program Medium

This program has been made available online.